Natco takes patent blitz honed in India to US pharma market

Natco expects to be among the first to win regulatory approval for its Copaxone generic, with sales anticipated to start in the next six months
09-04-2015
Bigul

Shareholding Pattern For March 31, 2015

Natco Pharma Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.
08-04-2015
Bigul

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Natco Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
06-04-2015
Bigul

Natco receives Generic Sofosbuvir (Sovaldi) approval for India

Natco Pharma Ltd has informed BSE regarding a Press Release dated March 12, 2015, titled "Natco receives Generic Sofosbuvir (Sovaldi) approval for India".
12-03-2015
Bigul

Supreme Court Agrees with NATCO and Denies petition for Certiorari on Generic Tamiflu Patent

Natco Pharma Ltd has informed BSE regarding a Press Release dated March 10, 2015, titled "Supreme Court Agrees with NATCO and Denies petition for Certiorari on Generic Tamiflu Patent".
10-03-2015
Bigul

NATCO launches HEPCINAT in Nepal- 1st generic version of Sofosbuvir (Sovaldi) in the country

Natco Pharma Ltd has informed BSE regarding a Press Release dated March 09, 2015 titled "NATCO launches HEPCINAT in Nepal- 1st generic version of Sofosbuvir (Sovaldi) in the country".
09-03-2015
Bigul

NATCO announces Licensing Agreement with Gilead Sciences

Natco Pharma Ltd has informed BSE regarding a Press Release dated March 02, 2015, titled "NATCO announces Licensing Agreement with Gilead Sciences".
02-03-2015
Bigul

NATCO announces USFDA Filing for Sorafenib Tablets, 200mg

Natco Pharma Ltd has informed BSE regarding a Press Release dated February 11, 2015 titled "NATCO announces USFDA Filing for Sorafenib Tablets, 200mg".
11-02-2015
Bigul

Results Press Release

Natco Pharma Ltd has submitted to BSE a copy of Results Press Release for the period ended December 31, 2014.
11-02-2015
Bigul

Fixes Record Date for Interim Dividend

Natco Pharma Ltd has informed BSE that the Company has fixed February 25, 2015 as the Record Date for the purpose of Payment of Interim Dividend. The said interim dividend pay-by-date is March 06, 2015.
11-02-2015
Next Page
Close

Let's Open Free Demat Account